文献速递炎症性肠病

人源微生物鞭毛蛋白驱动克罗恩病适应性免疫应答

Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
PubMed 文献 · Gastroenterology · 2021-05-07

研究开发微生物抗原微阵列,检测健康志愿者(n=87)、克罗恩病(n=152)和溃疡性结肠炎(n=170)患者血清对小鼠和人源鞭毛蛋白的IgG/IgA反应。克罗恩病患者对人源毛螺菌科鞭毛蛋白IgG升高,多鞭毛蛋白反应与T效应记忆细胞升高、Treg/Teff比值降低及并发症高发相关。

要点

  • 克罗恩病患者血清IgG对人源毛螺菌科鞭毛蛋白反应增强,溃疡性结肠炎无此表现。
  • 对超过10种鞭毛蛋白高反应的患者亚群,其鞭毛蛋白特异性CD154+CD45RA- T记忆细胞升高。
  • 多鞭毛蛋白反应与鞭毛蛋白反应性Treg/Teff比值降低及疾病并发症高频率相关。

核心结论

  • 克罗恩病患者对人源毛螺菌科鞭毛蛋白产生强烈适应性免疫应答,可能用于预后和未来个体化治疗。

研究设计与样本

  • 研究纳入阿拉巴马大学伯明翰分校健康志愿者87例,以及伯明翰医院Kirklin门诊招募的克罗恩病152例和溃疡性结肠炎170例患者。
  • 采用微生物抗原微阵列分别检测血清对小鼠和人源细菌鞭毛蛋白的IgG和IgA抗体反应。
  • 在部分患者中分离并评估循环鞭毛蛋白反应性T效应细胞(CD4+CD154+)和T调节细胞(CD4+CD137+)。
  • 将适应性免疫应答与相应临床数据比较,以确定其与疾病行为的相关性。

主要发现

  • 炎症性肠病患者对微生物鞭毛蛋白表现出选择性抗体反应模式。
  • 克罗恩病而非溃疡性结肠炎患者血清IgG对人回肠定位毛螺菌科鞭毛蛋白增强,部分患者对超过10种鞭毛蛋白高反应。
  • 对小鼠毛螺菌科鞭毛蛋白CBir1(临床用于诊断克罗恩病)的高反应与多毛螺菌科鞭毛蛋白反应性相关。
  • 在该克罗恩病亚群中,多鞭毛蛋白反应性与鞭毛蛋白特异性CD154+CD45RA- T记忆细胞升高、鞭毛蛋白反应性CD4+ T调节/T效应细胞比值降低及疾病并发症高频率相关。

临床怎么用

  • 对克罗恩病患者可关注人源毛螺菌科鞭毛蛋白抗体反应谱,辅助评估疾病行为及并发症风险。
  • 多鞭毛蛋白高反应亚群可能需更密切监测并发症,并为未来个体化治疗提供候选靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Crohn's disease and ulcerative colitis are characterized by dysregulated adaptive immune responses to the microbiota in genetically susceptible individuals, but the specificity of these responses remains largely undefined. Therefore, we developed a microbiota antigen microarray to characterize microbial antibody reactivity, particularly to human-derived microbiota flagellins, in inflammatory bowel disease. METHODS: Sera from healthy volunteers (n = 87) at the University of Alabama at Birmingham and from patients recruited from the Kirklin Clinic of University of Alabama at Birmingham Hospital, including patients with Crohn's disease (n = 152) and ulcerative colitis (n = 170), were individually probed against microbiota bacterial flagellins of both mouse and human origin and analyzed for IgG and IgA antibody responses. Circulating flagellin-reactive T effector (CD4+CD154+) and T regulatory (CD4+CD137+) cells were isolated and evaluated in selected patients. Resulting adaptive immune responses were compared with corresponding clinical data to determine relevancy to disease behavior. RESULTS: We show that patients with IBD express selective patterns of antibody reactivity to microbiota flagellins. Patients with Crohn's disease, but not patients with ulcerative colitis, display augmented serum IgG to human ileal-localized Lachnospiraceae flagellins, with a subset of patients having high responses to more than 10 flagellins. Elevated responses to CBir1, a mouse Lachnospiraceae flagellin used clinically to diagnose CD, correlated with multi-Lachnospiraceae flagellin reactivity. In this subset of patients with CD, multi-flagellin reactivity was associated with elevated flagellin-specific CD154+CD45RA- T memory cells, a reduced ratio of flagellin-reactive CD4+ T regulatory to T effector cells, and a high frequency of disease complications. CONCLUSIONS: Patients with Crohn's disease display strong adaptive immune response to human-derived Lachnospiraceae flagellins, which may be targeted for prognosis and future personalized therapies.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Alexander KL, Zhao Q, Reif M, et al. Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease. Gastroenterology. 2021. PMID: 33844987. doi:10.1053/j.gastro.2021.03.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。